JP2024543973A5 - - Google Patents

Info

Publication number
JP2024543973A5
JP2024543973A5 JP2024532491A JP2024532491A JP2024543973A5 JP 2024543973 A5 JP2024543973 A5 JP 2024543973A5 JP 2024532491 A JP2024532491 A JP 2024532491A JP 2024532491 A JP2024532491 A JP 2024532491A JP 2024543973 A5 JP2024543973 A5 JP 2024543973A5
Authority
JP
Japan
Prior art keywords
pharmaceutically acceptable
acceptable salt
compound according
alkyl
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024532491A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024543973A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/051493 external-priority patent/WO2023102100A1/en
Publication of JP2024543973A publication Critical patent/JP2024543973A/ja
Publication of JP2024543973A5 publication Critical patent/JP2024543973A5/ja
Pending legal-status Critical Current

Links

JP2024532491A 2021-12-01 2022-12-01 ムスカリン性アセチルコリン受容体m4のアンタゴニスト Pending JP2024543973A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163284750P 2021-12-01 2021-12-01
US63/284,750 2021-12-01
PCT/US2022/051493 WO2023102100A1 (en) 2021-12-01 2022-12-01 Antagonists of the muscarinic acetylcholine receptor m4

Publications (2)

Publication Number Publication Date
JP2024543973A JP2024543973A (ja) 2024-11-26
JP2024543973A5 true JP2024543973A5 (cg-RX-API-DMAC10.html) 2025-12-08

Family

ID=84943708

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024532491A Pending JP2024543973A (ja) 2021-12-01 2022-12-01 ムスカリン性アセチルコリン受容体m4のアンタゴニスト

Country Status (10)

Country Link
US (1) US20250145595A1 (cg-RX-API-DMAC10.html)
EP (1) EP4441046A1 (cg-RX-API-DMAC10.html)
JP (1) JP2024543973A (cg-RX-API-DMAC10.html)
KR (1) KR20240112343A (cg-RX-API-DMAC10.html)
CN (2) CN116669737A (cg-RX-API-DMAC10.html)
AU (1) AU2022400780A1 (cg-RX-API-DMAC10.html)
CA (1) CA3241298A1 (cg-RX-API-DMAC10.html)
IL (1) IL313219A (cg-RX-API-DMAC10.html)
MX (1) MX2024006718A (cg-RX-API-DMAC10.html)
WO (1) WO2023102100A1 (cg-RX-API-DMAC10.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3651762B1 (en) 2017-07-12 2024-07-03 Vanderbilt University Antagonists of the muscarinic acetylcholine receptor m4
JP7270989B2 (ja) 2017-10-20 2023-05-11 ヴァンダービルト ユニバーシティー ムスカリン性アセチルコリン受容体m4のアンタゴニスト
US12319701B2 (en) 2019-10-04 2025-06-03 Vanderbilt University Antagonists of the muscarinic acetylcholine receptor M4
JP2024500880A (ja) * 2020-12-22 2024-01-10 ヴァンダービルト ユニヴァーシティ ムスカリン性アセチルコリン受容体m4のアンタゴニスト
WO2022261427A1 (en) 2021-06-11 2022-12-15 Vanderbilt University (4-(6-((2-octahydrocyclopenta[c]pyrrol-5-yl)amino)pyridazin-3-yl)phenyl)(imino)(methyl)-lambda6- sulfanone derivatives and similar compounds as muscarinic acetylcholine receptor m4 antagonists for the treatment of neurodegenerative disorders

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102474326B1 (ko) * 2016-06-22 2022-12-05 반더빌트유니버시티 무스카린성 아세틸콜린 수용체 m4의 양성 알로스테릭 조절제
AU2018313802A1 (en) * 2017-08-08 2020-02-20 Vanderbilt University Antagonists of the muscarinic acetylcholine receptor M4
JP7270989B2 (ja) * 2017-10-20 2023-05-11 ヴァンダービルト ユニバーシティー ムスカリン性アセチルコリン受容体m4のアンタゴニスト
WO2021119254A1 (en) * 2019-12-10 2021-06-17 Vanderbilt University Antagonists of the muscarinic acetylcholine receptor m4
US20230183219A1 (en) * 2020-04-24 2023-06-15 Vanderbilt University Condensed substituted hydropyrroles as antagonists of the muscarinic acetylcholine receptor m4
CA3180717A1 (en) * 2020-04-24 2021-10-28 Vanderbilt University Condensed substituted hydropyrroles as antagonists of the muscarinic acetylcholine receptor m4

Similar Documents

Publication Publication Date Title
CN1057087C (zh) 取代的噁嗪和噻嗪噁唑烷酮抗微生物剂
KR101725696B1 (ko) 신규한 이환형 피리딘온
JP2022126779A (ja) オキサジアゾール一過性受容器電位チャネル阻害剤
EP4408832A1 (en) Novel prodrugs of mdma, mda, and derivatives thereof
JP2006513268A5 (ja) アンタゴニスト活性を有するベンゾアゾリルピペラジン誘導体
JP2024508545A5 (cg-RX-API-DMAC10.html)
JP2015524457A5 (cg-RX-API-DMAC10.html)
NO20072833L (no) Bi- og tricykliske substituterte fenylmetanoner som glycinetransportor I-(Glyt-1)-inhibitorer for behandling av Alzheimers sykdom
JP2022550459A5 (cg-RX-API-DMAC10.html)
US11912680B2 (en) Nitric oxide releasing prodrugs of MDA and MDMA
EP3288936B1 (en) Benzimidazolone and benzothiazolone compounds and their use as ampa receptor modulators
JP2018523665A5 (cg-RX-API-DMAC10.html)
JP2023533203A5 (cg-RX-API-DMAC10.html)
JP2021512109A5 (cg-RX-API-DMAC10.html)
RU2372350C2 (ru) НОВЫЕ ПРОИЗВОДНЫЕ 2-(1-АЗА-БИЦИКЛО[2.2.2]ОКТ-3-ИЛ)-2,3-ДИГИДРОИЗОИНДОЛ-1-ОНА/5,6-ДИГИДРО-ФУРО[2,3-c]ПИРРОЛ-4-ОНА В КАЧЕСТВЕ ЛИГАНДОВ К АЛЬФА 7 НИКОТИНОВОМУ АЦЕТИЛХОЛИНОВОМУ РЕЦЕПТОРУ
JP2007512283A5 (cg-RX-API-DMAC10.html)
JP2024508922A5 (cg-RX-API-DMAC10.html)
RU2008100019A (ru) Способ лечения чрезмерной дневной сонливости (варианты)
JP2022534709A5 (cg-RX-API-DMAC10.html)
JP2018520202A5 (cg-RX-API-DMAC10.html)
JP2023532985A5 (cg-RX-API-DMAC10.html)
RU2006124513A (ru) Производные бензоксазина и их применение
JP6911033B2 (ja) 極性非プロトン性溶媒を用いたn−[4−(1−アミノエチル)−フェニル]−スルホンアミド誘導体のキラル分割方法
JP6542236B2 (ja) 有機化合物
CN101525316A (zh) 喹啉类衍生物及其制备方法和用途